Innovation

Comments on Draft Scoping Document for Severe Asthma Therapies

June 4, 2018

As noted in ICER’s scoping document, uncontrolled asthma is a substantial problem that, according to the Centers for Disease Control and Prevention, afflicts 38.4 percent of children with asthma and 50 percent of adults with asthma. It is not clear from the scoping document, however, that ICER will adequately incorporate into its analysis several key issues associated with uncontrolled asthma.

Access, Disparities Issues Dominate Cardiovascular Health Policy Summit

May 18, 2018

A massive stroke marked a serious change in the weather for Mark McEwen, whose familiar face brought viewers the weather forecast on the 1990s’ “CBS This Morning.” McEwen keynoted the May 15 Cardiovascular Health Policy Summit in Washington, DC, describing how he struggled to regain speech, mobility and fine motor skills.

How Policymakers Can Redefine Pain Management

May 9, 2018

More than 42,000 Americans died from an opioid overdose in 2016.  Meanwhile, millions of other Americans suffer from chronic pain. The situation poses a difficult question for policymakers: How do we meet the needs of pain patients without contributing to the national opioid crisis?

Patents, Progress & Patient Access

April 10, 2018

Could a recent memorandum from the U.S. Patent and Trademark Office impact treatment options for patients?  Washington, DC’s nonprofit Bipartisan Policy Center says: Yes.

CAR-T Cancer Drugs Get Nod of Approval from ICER

January 23, 2018

Innovative but expensive CAR-T therapies for cancer are worth their price, announced the Institute for Clinical and Economic Review recently.  The organization is the self-appointed arbiter of drug costs.  But its decision was hardly news for those in the cancer community.

Medicare Patients Could Gain Access to Critical Diagnostic Test

January 12, 2018

Nearly 1.7 million Americans learned they had cancer in 2017. Most of these patients began traditional treatments like chemotherapy, radiation and surgery. Yet for many, a groundbreaking new immuno-oncology therapy could have been a better alternative.

Mind-Body Pain Treatments Pass ICER’s Cost-Effectiveness Test

October 11, 2017

Treating chronic low back pain with approaches such as yoga and talk therapy is cost effective, the Institute for Clinical and Economic Review announced this month.  Will health plans respond by expanding coverage for non-pharmacologic therapies?

The Price and Value of Orphan Drugs

September 22, 2017

How do you put a price tag on a drug that offers life-altering results – but for a small group of patients? The question is becoming increasingly relevant with the rise of innovative, targeted medicine.